awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35798947-034DCAE7-95BE-45F5-9DC6-933011AD7A16
Q35798947-034DCAE7-95BE-45F5-9DC6-933011AD7A16
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35798947-034DCAE7-95BE-45F5-9DC6-933011AD7A16
Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial.
P2860
Q35798947-034DCAE7-95BE-45F5-9DC6-933011AD7A16
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35798947-034DCAE7-95BE-45F5-9DC6-933011AD7A16
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bf77ab8fa542a143684fc7f91a7a1919c7af94a9
P2860
Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer.